Immunohistochemical and quantitative mRNA assessment of ghrelin expression in gastric and oesophageal adenocarcinoma
- Marcus Mottershead1,
- Emmanuel Karteris2,
- Jill Y Barclay2,
- Saira Suortamo1,
- Mark Newbold1,
- Harpal Randeva2,
- Chuka U Nwokolo1
- 1Departments of Gastroenterology and Pathology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK
- 2Biomedical Research Institute, University of Warwick, Warwick, UK
- Correspondence to:
Professor C U Nwokolo
Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry CV2 2DX, UK; chukanwokolo{at}compuserve.com
- Accepted 25 April 2006
- Published Online First 2 June 2006
Abstract
Background: Ghrelin is an orexigenic gut peptide produced predominantly by the stomach. Gastric mucosal ghrelin production could be compromised by an infiltrating adenocarcinoma.
Aims: To assess the expression of ghrelin mRNA and peptide in oesophagogastric adenocarcinomas and adjacent non-neoplastic mucosa.
Methods: 10 gastric and 22 oesophageal adenocarcinoma archival samples were randomly selected from a database. The presence of ghrelin-positive cells was assessed in cancer and corresponding non-neoplastic mucosa by immunohistochemistry. Quantitative reverse transcriptase polymerase chain reaction (PCR) for ghrelin mRNA was also performed on 24 gastric and 8 oesophageal adenocarcinoma specimens and adjacent non-neoplastic mucosa.
Results: Immunohistochemistry and reverse transcriptase PCR confirm a negligible expression of ghrelin in adenocarcinoma specimens. By contrast, non-neoplastic gastric mucosa was rich in ghrelin-positive cells and ghrelin mRNA. The number (median and range) of ghrelin-positive cells per 2 mm section of non-neoplastic mucosa was 73 (45–215) in the corpus; this was significantly higher than in cardia mucosa (9 (0–64), p<0.001) and antral mucosa (5 (0–14), p<0.001).
Conclusions: Gastric and oesophageal adenocarcinomas have no ghrelin-producing cells. The highest level of ghrelin expression was noted in the non-neoplastic mucosa of the gastric corpus. Disruption of the gastric ghrelin-producing mechanism may occur during oesophagogastric malignancy.
Footnotes
-
Published Online First 2 June 2006
-
Competing interests: None.
-
Ethical considerations: The Coventry Research Ethics Committee gave ethical approval. Patients gave written informed consent for samples collected peri-operatively.
